274
|
826
|
9bh7A |
Human dna polymerase theta helicase domain dimer in the apo form |
259
|
825
|
9bh8A |
Human dna polymerase theta helicase domain dimer bound to dna in the microhomology searching conformation |
261
|
826
|
9bhaA |
Human dna polymerase theta helicase domain dimer bound to dna in the microhomology annealed conformation |
274
|
826
|
9bh6A |
Human dna polymerase theta helicase domain tetramer in the apo form |
247
|
825
|
9bh9A |
Human dna polymerase theta helicase domain dimer bound to dna in the microhomology aligning conformation |
90
|
300
|
9emjA |
Sars-cov-2 methyltransferase nsp10-16 in complex with toyocamycin and m7gpppa (cap0-analog) |
29
|
131
|
8th5A |
Crystal structure of the g3bp1 ntf2-like domain bound to the idr1 of sars-cov-2 nucleocapsid protein p13l mutant |
90
|
299
|
8s8wA |
Sars-cov-2 nsp10-16 methyltransferase in complex with sangivamycin and m7gpppa-rna (cap0-rna) |
32
|
136
|
8th7A |
Crystal structure of the g3bp1 ntf2-like domain bound to the caprin1 peptide |
26
|
116
|
9emlB |
Sars-cov-2 methyltransferase nsp10-16 in complex with sam and m7gpppa (cap0-analog)/m7gpppam (cap1-analog) |
88
|
300
|
9emvA |
Sars-cov-2 nsp10-16 methyltransferase in complex with sangivamycin and m7gpppa (cap0-analog)/m7gpppam (cap1-analog) |
95
|
318
|
8vecA |
Deep mutational scanning of sars-cov-2 plpro |
10
|
58
|
8yjmB |
Structure of human spt16 md-ctd and mcm2 hbd chaperoning a histone h3-h4 tetramer and a single chain h2b-h2a chimera |
24
|
116
|
9emjB |
Sars-cov-2 methyltransferase nsp10-16 in complex with toyocamycin and m7gpppa (cap0-analog) |
33
|
138
|
8th6A |
Crystal structure of the g3bp1 ntf2-like domain bound to usp10 peptide |
25
|
114
|
8s8xB |
Sars-cov-2 nsp10-16 methyltransferase in complex with toyocamycin and m7gpppa-rna (cap0-rna) |
93
|
301
|
8s8xA |
Sars-cov-2 nsp10-16 methyltransferase in complex with toyocamycin and m7gpppa-rna (cap0-rna) |
25
|
114
|
8s8wB |
Sars-cov-2 nsp10-16 methyltransferase in complex with sangivamycin and m7gpppa-rna (cap0-rna) |
8
|
60
|
8yjfB |
Structure of human spt16 md-ctd and mcm2 hbd chaperoning a histone h3-h4 tetramer and an h2a-h2b dimer |
93
|
300
|
9emlA |
Sars-cov-2 methyltransferase nsp10-16 in complex with sam and m7gpppa (cap0-analog)/m7gpppam (cap1-analog) |
24
|
115
|
9emvB |
Sars-cov-2 nsp10-16 methyltransferase in complex with sangivamycin and m7gpppa (cap0-analog)/m7gpppam (cap1-analog) |
83
|
300
|
8intA |
Crystal structure of sars-cov-2 main protease (mpro) k90r mutant |
85
|
300
|
8inqA |
Crystal structure of sars-cov-2 main protease (mpro) g15s mutant |
85
|
306
|
8inwA |
Crystal structure of sars-cov-2 main protease (mpro) k90r mutant in complex with inhibitor nirmatrelvir |
86
|
306
|
8inuA |
Crystal structure of sars-cov-2 main protease (mpro) g15s mutant in complex with inhibitor nirmatrelvir |
84
|
301
|
8inxA |
Crystal structure of sars-cov-2 main protease (mpro) g15s mutant in complex with inhibitor ensitrelvir |
83
|
301
|
8inyA |
Crystal structure of sars-cov-2 main protease (mpro) k90r mutant in complex with inhibitor ensitrelvir |
33
|
80
|
8ya8A |
The crystal structure of human rtel1 hhd2 domain |
248
|
928
|
8gwmA |
Sars-cov-2 e-rtc bound with mmp-nsp9 and gmppnp |
245
|
931
|
8gwkA |
Sars-cov-2 rna e-rtc complex with rmp-nsp9 and gmppnp |
100
|
592
|
8gwkE |
Sars-cov-2 rna e-rtc complex with rmp-nsp9 and gmppnp |
94
|
592
|
8gwmE |
Sars-cov-2 e-rtc bound with mmp-nsp9 and gmppnp |
14
|
113
|
8gwmG |
Sars-cov-2 e-rtc bound with mmp-nsp9 and gmppnp |
43
|
187
|
8gwkB |
Sars-cov-2 rna e-rtc complex with rmp-nsp9 and gmppnp |
46
|
187
|
8gwmB |
Sars-cov-2 e-rtc bound with mmp-nsp9 and gmppnp |
18
|
113
|
8gwkG |
Sars-cov-2 rna e-rtc complex with rmp-nsp9 and gmppnp |
95
|
296
|
8rzdA |
Sars-cov-2 nsp16-nsp10 in complex with sam derivative inhibitor 9 |
99
|
296
|
8rzcA |
Sars-cov-2 nsp16-nsp10 in complex with sam derivative inhibitor 11 |
98
|
296
|
8rzeA |
Sars-cov-2 nsp16-nsp10 in complex with sam derivative inhibitor 10 |
93
|
305
|
8cdcA |
Native 3clpro from sars-cov-2 at 1.54 a |
88
|
305
|
8tpbA |
Synthesis, x-ray crystallographic and biological activities of covalent, non-peptidic inhibitors of sars-cov-2 main protease |
87
|
305
|
8tphA |
Synthesis, x-ray crystallographic and biological activities of covalent, non-peptidic inhibitors of sars-cov-2 main protease |
87
|
305
|
8tpeA |
Synthesis, x-ray crystallographic and biological activities of covalent, non-peptidic inhibitors of sars-cov-2 main protease |
28
|
114
|
8tyjB |
Crystal structure of sars-cov-2 nsp10/nsp16 complex with bound sah |
82
|
305
|
8tpiA |
Synthesis, x-ray crystallographic and biological activities of covalent, non-peptidic inhibitors of sars-cov-2 main protease |
95
|
296
|
8tyjA |
Crystal structure of sars-cov-2 nsp10/nsp16 complex with bound sah |
84
|
305
|
8tpfA |
Synthesis, x-ray crystallographic and biological activities of covalent, non-peptidic inhibitors of sars-cov-2 main protease |
87
|
305
|
8tpcA |
Synthesis, x-ray crystallographic and biological activities of covalent, non-peptidic inhibitors of sars-cov-2 main protease |
89
|
305
|
8tpdA |
Synthesis, x-ray crystallographic and biological activities of covalent, non-peptidic inhibitors of sars-cov-2 main protease |
83
|
305
|
8tpgA |
Synthesis, x-ray crystallographic and biological activities of covalent, non-peptidic inhibitors of sars-cov-2 main protease |